Search Results - "Pathil‐Warth, A."

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study by Lampertico, Pietro, Berg, Thomas, Buti, Maria, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D., Zoulim, Fabien, Botros, Irina, Flaherty, John F., Jump, Belinda, Op den Brouw, Marjoleine L., Troostenburg, Anna, Ramroth, Heribert, Bourlière, M., De Ledinghen, V., Riachi, G., Zoulim, F., Loustaud‐Ratti, V., Tran, A., Larrey, D., Dumortier, J., Leroy, V., Metivier, S., Sellier, P., Mauss, S., Peterson, J., Berg, T., Schiefke, I., Niederau, C., Teuber, G., Goeser, T., Jung, M. C., Grambihler, A., Pathil‐Warth, A., Sprinzl, K., Von der Ohe, M., Antoni, C., Weigand, K., Andreone, P., Lampertico, P., Di Marco, V., Madonia, S., Puoti, M., Santantonio, T., Vigano, M., Ciancio, A., D'Offizi, G., Pirisi, M., Buti, M., Suarez Garcia, E., Pascasio Acevedo, J. M, Andrade, R., Gea, F., Serra Desfilis, M. A., Molina Perez, E., Manzano Alonso, M., Carrion, J. A., Aoufi Rabih, S., Planas, M. M., Ryder, S., Agarwal, K., Ustianowski, A., Aspinall, R., Kennedy, P., Geretti, A. M., McCorry, R., Foxton, M., Healy, B.

“…Summary Background Limited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectiveness in chronic hepatitis B virus–infected (CHB)…”
Get full text

P0934 : Lysophosphatidylcholine (LPC) as central player for hepatic fat accumulation and inflammation: Implication for pathogenesis of NASH by Stremmel, W, Staffer, S, Wannhoff, A, Pathil-Warth, A, Chamulitrat, W

Get full text

High SVR 12 rates following treatment with direct acting antiviral agents (DAA) in a German multicentre cohort of HCV/HIV-1 coinfected patients on the transplant waiting list with advanced liver cirrhosis by Schwarz, J, Werner, C, Steurer, M, Spengler, U, Wedemeyer, H, von Hahn, T, Stremmel, W, Pathil-Warth, A, Berg, T, Engelmann, C, Seybold, U, Schott, E, Blessin, U, Malek, N, Lauer, U, Berg, C

Get full text

Add on Interferon-Alpha-2a for the Treatment of HBeAg Negative Hepatitis B Patients Receiving Effective Nucleos(t)ide Therapy: Interim Results of the Prospective Multicentre PADD-On Trial by Sprinzl, M.F, Grambihler, A, Teuber, G, Ebert, M, Zeuzem, S, Lohmeyer, J, Cornberg, M, Tacke, F, Löhr, H, Berg, T, Lammert, F, Schott, E, Heyne, R, Berg, C, Dollinger, M, Pathil-Warth, A, Geisler, F, Spengler, U, Thimme, R, Weigand, K, Alshuth, U, Ehrlich, A, Riedl, M, Kittner, J, Schuchmann, M, Galle, P.R

Get full text

20 DEFICIENCIES OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2 BETA IN VIVO CAUSES REDUCED SYSTEMIC LIPIDS AND LIPOPROTEINS CONCOMITANT WITH INCREASED HEPATIC APOPTOSIS AND INFLAMMATION by Xu, W, Tuma, S, Katava, N, Pathil-Warth, A, Stremmel, W, Chamulitrat, W

Get full text

First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany - a survey in university hospital centers of hepatology by Weiss, J, Rau, M, Bantel, H, Bock, H, Demir, M, Kluwe, J, Krawczyk, M, Pathil-Warth, A, Schattenberg, J M, Tacke, F, Roeb, E, Geier, A

“…Non-alcoholic fatty liver disease (NAFLD) currently is one oft the most common reasons for chronic liver injury in the western world. In the European and…”
Get more information

1221 URSODEOXYCHOLYL LYSOPHOSPHATIDYLETHANOLAMIDE GENERATES HEPATOPROTECTIVE CONJUGATED UDCA, PHOSPHATIDYLCHOLINE, MEDIUM-CHAIN FATTY ACIDS AND PLASMALOGEN 16:1 by Chamulitrat, W, Xu, W, Pathil-Warth, A, Liebisch, G, Schmitz, G, Zhang, W, Setchell, K, Stremmel, W

Get full text

138 A NOVEL BILE SALT-PHOSPHOLIPID CONJUGATE URSODEOXYCHOLYL-LYSOPHOSPHATIDYLETHANOLAMIDE AS A HEPATIC CYTOPROTECTIVE AGENT by Chamulitrat, W, Burhenne, J, Rehlen, T, Pathil-Warth, A, Stremmel, W

Get full text

FRI-259 - High SVR 12 rates following treatment with direct acting antiviral agents (DAA) in a German multicentre cohort of HCV/HIV-1 coinfected patients on the transplant waiting list with advanced liver cirrhosis by Schwarz, J., Werner, C., Steurer, M., Spengler, U., Wedemeyer, H., von Hahn, T., Stremmel, W., Pathil-Warth, A., Berg, T., Engelmann, C., Seybold, U., Schott, E., Blessin, U., Malek, N., Lauer, U., Berg, C.

Get full text

LBP517 - Add on Interferon-Alpha-2a for the Treatment of HBeAg Negative Hepatitis B Patients Receiving Effective Nucleos(t)ide Therapy: Interim Results of the Prospective Multicentre PADD-On Trial by Sprinzl, M.F., Grambihler, A., Teuber, G., Ebert, M., Zeuzem, S., Lohmeyer, J., Cornberg, M., Tacke, F., Löhr, H., Berg, T., Lammert, F., Schott, E., Heyne, R., Berg, C., Dollinger, M., Pathil-Warth, A., Geisler, F., Spengler, U., Thimme, R., Weigand, K., Alshuth, U., Ehrlich, A., Riedl, M., Kittner, J., Schuchmann, M., Galle, P.R.

Get full text

The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial by Casper, Markus, Mengel, Martin, Fuhrmann, Christine, Herrmann, Eva, Appenrodt, Beate, Schiedermaier, Peter, Reichert, Matthias, Bruns, Tony, Engelmann, Cornelius, Grünhage, Frank, Lammert, Frank

“…Patients with liver cirrhosis have a highly elevated risk of developing bacterial infections that significantly decrease survival rates. One of the most…”
Get full text

Arzneimitteltherapie in der Schwangerschaft: Einschätzung von Risiken und Chancen by Blank, A., Eidam, A., Lampert, A., Pathil-Warth, A., Mikus, G.

“…Zusammenfassung Arzneimittel für schwangere Frauen können durch Therapie von Erkrankungen großen Nutzen, aber auch Gefahren durch Toxizität auf…”
Get full text

Neue Aspekte zur Pathogenese der NASH by Stremmel, W., Pathil-Warth, A., Chamulitrat, W.

“…Zusammenfassung Die nichtalkoholische Fettlebererkrankung (NAFLD) und die nichtalkoholische Fettleberhepatitis (NASH) beschreiben ätiologisch nicht vollständig…”
Get full text

S2k Guideline non-alcoholic fatty liver disease by Roeb, E, Steffen, H M, Bantel, H, Baumann, U, Canbay, A, Demir, M, Drebber, U, Geier, A, Hampe, J, Hellerbrand, C, Pathil-Warth, A, Schattenberg, J M, Schramm, C, Seitz, H K, Stefan, N, Tacke, F, Tannapfel, A, Lynen Jansen, P, Bojunga, J

Get more information